Pembrolizumab 25 MG/ML [Keytruda] Clinical Trials
3 recruitingDrug
Phase 22Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 2
Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT
Small Cell Ovarian Carcinoma
ARCAGY/ GINECO GROUP27 enrolled13 locationsNCT04602377
Recruiting
Phase 2
Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
Adrenocortical Carcinoma
Maria Sklodowska-Curie National Research Institute of Oncology24 enrolled4 locationsNCT05563467
Recruiting
Phase 3
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Lung Cancer, Nonsmall Cell
Imperial College London1,750 enrolled37 locationsNCT05085028